These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30303536)

  • 1. From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America.
    Vaccaro CA; López-Kostner F; Adriana DV; Palmero EI; Rossi BM; Antelo M; Solano A; Carraro DM; Forones NM; Bohorquez M; Lino-Silva LS; Buleje J; Spirandelli F; Abe-Sandes K; Nascimento I; Sullcahuaman Y; Sarroca C; Gonzalez ML; Herrando AI; Alvarez K; Neffa F; Galvão HC; Esperon P; Golubicki M; Cisterna D; Cardoso FC; Torrezan GT; Junior SA; Pimenta CAM; da Cruz Formiga MN; Santos E; Sá CU; Oliveira EP; Fujita R; Spirandelli E; Jimenez G; Guindalini RSC; de Azevedo RGMV; Bueno LSM; Dos Santos Nogueira ST; Loarte MT; Padron J; Del Carmen Castro-Mujica M; Del Monte JS; Caballero C; Peña CMM; Pinto J; Barletta-Carrillo C; Melva GA; Piñero T; Beltran PM; Ashton-Prolla P; Rodriguez Y; Quispe R; Rossi NT; Martin C; Chialina S; Kalfayan PG; Bazo-Alvarez JC; Cañete AR; Dominguez-Barrera C; Nuñez L; Da Silva SD; Balavarca Y; Wernhoff P; Plazzer JP; Møller P; Hovig E; Dominguez-Valentin M;
    Int J Cancer; 2019 Jul; 145(2):318-326. PubMed ID: 30303536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.
    Rossi BM; Palmero EI; López-Kostner F; Sarroca C; Vaccaro CA; Spirandelli F; Ashton-Prolla P; Rodriguez Y; de Campos Reis Galvão H; Reis RM; Escremim de Paula A; Capochin Romagnolo LG; Alvarez K; Della Valle A; Neffa F; Kalfayan PG; Spirandelli E; Chialina S; Gutiérrez Angulo M; Castro-Mujica MDC; Sanchez de Monte J; Quispe R; da Silva SD; Rossi NT; Barletta-Carrillo C; Revollo S; Taborga X; Morillas LL; Tubeuf H; Monteiro-Santos EM; Piñero TA; Dominguez-Barrera C; Wernhoff P; Martins A; Hovig E; Møller P; Dominguez-Valentin M
    BMC Cancer; 2017 Sep; 17(1):623. PubMed ID: 28874130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries.
    Della Valle A; Rossi BM; Palmero EI; Antelo M; Vaccaro CA; López-Kostner F; Alvarez K; Cruz-Correa M; Bruno LI; Forones NM; Mindiola JAR; Buleje J; Spirandelli F; Bohorquez M; Cock-Rada AM; Sullcahuaman Y; Nascimento I; Abe-Sandes K; Lino-Silva LS; Petracchi F; Mampel A; Rodriguez Y; Rossi NT; Yañez CB; Rubio C; Petta-Lajus TB; Silveira-Lucas EL; Jiménez G; Peña CMM; Reyes-Silva C; Ayala-Madrigal ML; Del Monte JS; Quispe R; Recalde A; Neffa F; Sarroca C; de Campos Reis Galvão H; Golubicki M; Piñero TA; Kalfayan PG; Ferro FA; Gonzalez ML; Pérez-Mayoral J; Pimenta CAM; Uyaban SPB; Protzel A; Chávez G; Dueñas M; Gil MLG; Spirandelli E; Chialina S; Echeverry M; Fuenmayor LJP; Torres M; Palma TFB; Héritas NC; Martin C; Suárez A; Vallejo M; Rafaela de Souza Timoteo A; Ayala CA; Jaramillo-Koupermann G; Hernández-Sandoval JA; Guerrero AH; Dominguez-Barrera C; Bazo-Alvarez JC; Wernhoff P; Plazzer JP; Balavarca Y; Hovig E; Møller P; Dominguez-Valentin M;
    Eur J Cancer; 2019 Sep; 119():112-121. PubMed ID: 31442815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
    Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
    Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
    Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
    Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
    Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
    Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing strategies to reduce morbidity and mortality from Lynch syndrome.
    Keränen A; Ghazi S; Carlson J; Papadogiannakis N; Lagerstedt-Robinson K; Lindblom A
    Scand J Gastroenterol; 2018 Dec; 53(12):1535-1540. PubMed ID: 30572730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome.
    Cruz-Correa M; Diaz-Algorri Y; Pérez-Mayoral J; Suleiman-Suleiman W; Gonzalez-Pons Mdel M; Bertrán C; Casellas N; Rodríguez N; Pardo S; Rivera K; Mosquera R; Rodriguez-Quilichini S
    Fam Cancer; 2015 Sep; 14(3):415-25. PubMed ID: 25782445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
    Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Jenkins M; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Möslein G; Sampson JR; Capella G;
    Gut; 2017 Sep; 66(9):1657-1664. PubMed ID: 27261338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing.
    Piñero TA; Soukarieh O; Rolain M; Alvarez K; López-Köstner F; Torrezan GT; Carraro DM; De Oliveira Nascimento IL; Bomfim TF; Machado-Lopes TMB; Freitas JC; Toralles MB; Sandes KA; Rossi BM; Junior SA; Meira J; Dominguez-Valentin M; Møller P; Vaccaro CA; Martins A; Pavicic WH
    Fam Cancer; 2020 Oct; 19(4):323-336. PubMed ID: 32363481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
    Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.
    Vasen HFA
    Fam Cancer; 2022 Jan; 21(1):49-56. PubMed ID: 33464460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population.
    Padua-Bracho A; Velázquez-Aragón JA; Fragoso-Ontiveros V; Nuñez-Martínez PM; Mejía Aguayo ML; Sánchez-Contreras Y; Ramirez-Otero MA; De la Fuente-Hernández MA; Vidal-Millán S; Wegman-Ostrosky T; Pedroza-Torres A; Arriaga-Canon C; Herrera-Montalvo LA; Alvarez-Gómez RM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.
    Takeda T; Tsuji K; Banno K; Yanokura M; Kobayashi Y; Tominaga E; Aoki D
    J Gynecol Oncol; 2018 May; 29(3):e29. PubMed ID: 29400022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.